| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000001179 |
| Receipt No. | R000001443 |
| Scientific Title | Endothelial Function in Subjects with Isolated Low HDL Cholesterol: Role of Nitric Oxide and Endothelial Progenitor Cells |
| Date of disclosure of the study information | 2008/06/10 |
| Last modified on | 2021/07/02 (Ver. 2) |
| Basic information | ||
| Public title | Endothelial Function in Subjects with Isolated Low HDL Cholesterol: Role of Nitric Oxide and Endothelial Progenitor Cells | |
| Acronym | Low HDL Study | |
| Scientific Title | Endothelial Function in Subjects with Isolated Low HDL Cholesterol: Role of Nitric Oxide and Endothelial Progenitor Cells | |
| Scientific Title:Acronym | Low HDL Study | |
| Region |
|
|
| Condition | ||
| Condition | Subjects with isolated low HDL cholesterol | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study was to determine the contribution of isolated low HDL cholesterol to endothelial function. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Endothelial function (FMD) |
| Key secondary outcomes | Endothelial progenitor cell function |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Anti-dyslipidemic agent (pravastatin) | |
| Interventions/Control_2 | placebo | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects with isolated HDL cholesterol | |||
| Key exclusion criteria | Subjects with low HDL cholesterol who had other cardiovascular risk factors such as elevated levels of blood pressure, cholesterol, glucose and smoking habit | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hiroshima University | ||||||
| Division name | Graduate School of Biomedical Sciences | ||||||
| Zip code | |||||||
| Address | 1-2-3 Kasumi, Mimami-ku, Hiroshima 734-8551, Japan | ||||||
| TEL | 082-257-5122 | ||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hiroshima University | ||||||
| Division name | Graduate School of Biomedical Sciences | ||||||
| Zip code | |||||||
| Address | 1-2-3 Kasumi, Mimami-ku, Hiroshima 734-8551, Japan | ||||||
| TEL | 082-257-5122 | ||||||
| Homepage URL | http://home.hiroshima-u.ac.jp/angio | ||||||
| yhigashi@hiroshima-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Cardiovascular Physiology and Medicine, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hiroshima University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001443 |